Development and validation of a five-gene palmitoylation-associated prognostic model in acute myeloid leukemia
Open Access
- 7 September 2026
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Abstract
No abstract availableKeywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (2024-I2M-C&T-B-082)
This publication has 32 references indexed in Scilit:
- Targeting palmitoylation: A novel frontier in cancer biology and immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis EvasionAdvanced Science, 2025
- Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and ManagementAmerican Journal of Hematology, 2025
- Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategiesAnnals of Hematology, 2024
- A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AMLCell Reports Medicine, 2024
- Acute myeloid leukaemiaThe Lancet, 2023
- Protein palmitoylation in cancer: molecular functions and therapeutic potentialMolecular Oncology, 2022
- Catch me if you can: how AML and its niche escape immunotherapyLeukemia, 2021
- Enhanced monoacylglycerol lipolysis by ABHD6 promotes NSCLC pathogenesisEBioMedicine, 2020
- APT2 Inhibition Restores Scribble Localization and S -Palmitoylation in Snail-Transformed CellsCell Chemical Biology, 2017